According to Biocon's latest financial reports the company has $0.47 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $0.34 B | 31.42% |
2022-03-31 | $0.26 B | -26.63% |
2021-03-31 | $0.35 B | 157.02% |
2020-03-31 | $0.13 B | -17.44% |
2019-03-31 | $0.16 B | -42.99% |
2018-03-31 | $0.29 B | -8.75% |
2017-03-31 | $0.32 B | -10.46% |
2016-03-31 | $0.36 B | 94.62% |
2015-03-31 | $0.18 B | -25.7% |
2014-03-31 | $0.25 B | 14.23% |
2013-03-31 | $0.22 B | 10.32% |
2012-03-31 | $0.19 B | 5.86% |
2011-03-31 | $0.18 B | 503.24% |
2010-03-31 | $31.23 M | 1243.62% |
2009-03-31 | $2.32 M | -3.58% |
2008-03-31 | $2.41 M | 19.19% |
2007-03-31 | $2.02 M | 345.06% |
2006-03-31 | $0.45 M | -42.11% |
2005-03-31 | $0.78 M | -98.93% |
2004-03-31 | $73.27 M |